We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BMRA market cap is 9.92M. The company's latest EPS is USD -0.4245 and P/E is -1.39.
Quarter End | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 1.48M | 1.11M | 1.11M | 1.71M | 1.57M |
Operating Income | -1.67M | -1.65M | -1.84M | -1.23M | -1.61M |
Net Income | -1.63M | -1.65M | -1.79M | -1.13M | -1.51M |
Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 5.2M | 6.69M | 7.2M | 18.87M | 5.34M |
Operating Income | -2.51M | -2.4M | -6.52M | -4.53M | -7.22M |
Net Income | -2.49M | -2.34M | -6.47M | -4.53M | -7.14M |
Quarter End | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 9.91M | 8.21M | 14.45M | 13.22M | 11.83M |
Total Liabilities | 2.67M | 2.22M | 2.73M | 2.45M | 2.45M |
Total Equity | 7.24M | 5.99M | 11.72M | 10.77M | 9.38M |
Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 5.25M | 17.26M | 11.82M | 11.37M | 14.45M |
Total Liabilities | 1.26M | 3.05M | 2.59M | 3.05M | 2.73M |
Total Equity | 3.98M | 14.21M | 9.23M | 8.33M | 11.72M |
Quarter End | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -2.79M | -4.51M | -5.44M | -1.67M | -2.52M |
Investing | -58k | -64k | -78k | -63k | -75k |
Financing | 2.02M | 2.04M | 9.39M | N/A | N/A |
Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -2.24M | -4.3M | -5.25M | -481k | -5.44M |
Investing | -171k | -119k | -295k | -170k | -78k |
Financing | 1.91M | 12.37M | 1.11M | 2.4M | 9.39M |
Market Cap | 9.92M |
Price to Earnings Ratio | -1.39 |
Price to Sales Ratio | 1.86 |
Price to Cash Ratio | 1.02 |
Price to Book Ratio | 0.85 |
Dividend Yield | - |
Shares Outstanding | 16.82M |
Average Volume (1 week) | 324.92k |
Average Volume (1 Month) | 556.58k |
52 Week Change | -58.16% |
52 Week High | 2.13 |
52 Week Low | 0.50 |
Spread (Intraday) | 0.02 (4.2%) |
Company Name | Biomerica Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.biomerica.com |
Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions